Rights Offering: 105.4B Won for Operations, Issue Price 4,860 Won
-
Final issue price: 4,860 won, issuing 16,830,200 new shares (dilution 22.63%)
-
Purpose: operating funds of 105,357,052,000 won (increased from initial 81,794,772,000 won)
-
Subscription for existing shareholders: May 13-14, 2026; public offering: May 18-19, 2026
-
Pre-emptive rights certificates to be listed on KRX (April 24-30, 2026)
-
Short selling ban period: February 7 - May 8, 2026
KOSDAQ Filing Information
-
Filing: [Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)
-
Company: ImmuneOncia Therapeutics (424870)
-
Submission: ImmuneOncia Therapeutics, Inc.
-
Receipt: 05-11-2026